LMRI (Lumexa Imaging Holdings) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


LMRI Lumexa Imaging Holdings Inc LMRI
8 GF Score
Price $12.10
! 2 Warning Signs
View Full Analysis

What is Lumexa Imaging Holdings Research & Development?

Lumexa Imaging Holdings LMRI +14.37% 8 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Lumexa Imaging Holdings's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Lumexa Imaging Holdings  (NAS:LMRI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lumexa Imaging Holdings Research & Development Related Terms

Lumexa Imaging Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Lumexa Imaging Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumexa Imaging Holdings Research & Development Chart

Lumexa Imaging Holdings Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00

Lumexa Imaging Holdings Quarterly Data
Dec23 Dec24 Mar25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
LMRI
8GF Score
Lumexa Imaging Holdings Inc LMRI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumexa Imaging Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Lumexa Imaging Holdings (LMRI) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Lumexa Imaging Holdings and its competitors.
Is Lumexa Imaging Holdings' Research & Development too high?
Lumexa Imaging Holdings' current Research & Development is $0.0 Mil. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' Research & Development compare to SSII and CBLL?
Lumexa Imaging Holdings' Research & Development of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Lumexa Imaging Holdings and its competitors. Lumexa Imaging Holdings's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current Research & Development of $0.0 Mil. The current Research & Development is $0.0 Mil. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumexa Imaging Holdings Business Description

Address 4200 Six Forks Road, Suite 1000, Raleigh, NC, USA, 27609
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score

Get the complete analysis for LMRI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.10
Price